|
DDX42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37509999997842E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71000003046373E-09 |
| Normal-vs-Stage2 |
1.670230E-01 |
| Normal-vs-Stage3 |
1.526240E-02 |
| Normal-vs-Stage4 |
1.045440E-01 |
| Stage1-vs-Stage2 |
1.491710E-02 |
| Stage1-vs-Stage3 |
2.936000E-03 |
| Stage1-vs-Stage4 |
1.122600E-03 |
| Stage2-vs-Stage3 |
7.793600E-01 |
| Stage2-vs-Stage4 |
8.453600E-01 |
| Stage3-vs-Stage4 |
5.400200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.84440000003694E-06 |
| Normal-vs-AfricanAmerican |
2.903800E-03 |
| Normal-vs-Asian |
4.624000E-04 |
| Caucasian-vs-AfricanAmerican |
5.449800E-01 |
| Caucasian-vs-Asian |
1.634240E-01 |
| AfricanAmerican-vs-Asian |
3.021400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.388000E-04 |
| Normal-vs-Female |
1.44520000411319E-08 |
| Male-vs-Female |
4.343300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.014030E-01 |
| Normal-vs-Age(41-60Yrs) |
3.78739999999933E-05 |
| Normal-vs-Age(61-80Yrs) |
1.55856999999315E-05 |
| Normal-vs-Age(81-100Yrs) |
1.948050E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.141200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.520200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.548200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.842600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.639000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.034600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.11060000085317E-08 |
| Normal-vs-Grade 2 |
4.62920002330947E-09 |
| Normal-vs-Grade 3 |
2.618400E-03 |
| Normal-vs-Grade 4 |
1.633190E-01 |
| Grade 1-vs-Grade 2 |
5.739900E-02 |
| Grade 1-vs-Grade 3 |
1.418750E-03 |
| Grade 1-vs-Grade 4 |
2.834600E-04 |
| Grade 2-vs-Grade 3 |
1.641760E-03 |
| Grade 2-vs-Grade 4 |
1.418480E-03 |
| Grade 3-vs-Grade 4 |
3.232200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.80888637402177E-12 |
| Normal-vs-ccB subtype |
7.068400E-02 |
| ccA subtype-vs-ccB subtype |
1.10839999956092E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.181870E-04 |
| Normal-vs-N1 |
2.256400E-01 |
| N0-vs-N1 |
8.089400E-01 |
|
|
